, Hawthorne, NY
Acorda is engaged in the
development of therapeutics for spinal cord injury and other central
nervous system conditions. Some of its products may also have
applications in other neurological injury markets, including head
trauma, multiple sclerosis and stroke. The company has a strategic
partnership with Elan Corporation plc.